By: IPP Bureau
Last updated : October 25, 2024 9:13 am
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024
Jagsonpal Pharmaceuticals Limited has reported Standalone financial results for the period ended September 30, 2024.
Jagsonpal Pharmaceuticals has posted net profit of Rs. 11.45 crores for the period ended September 30, 2024 as against net profit of Rs. 5.32 crores for the period ended June 30, 2024. The company posted net profit of Rs.7.47 crores for the period ended September 30, 2023.
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024 as compared to Rs. 62.88 crores during the period ended June 30, 2024. The company reported total income of Rs. 60.10 crores during the period ended September 30, 2023.
For the Half Year ended FY25, Jagsonpal Pharmaceuticals has reported total income of Rs.139.22 crores as compared to Rs.122.25 crores during the 6 months period ended September 30, 2023.
The company has posted net profit of Rs.16.78 crores for the 6 months period ended September 30, 2024 as against net profit of Rs.14.95 crores for the 6 Months period ended September 30, 2023.